2008
Use of Recommended Ambulatory Care Services: Is the Veterans Affairs Quality Gap Narrowing?
Ross JS, Keyhani S, Keenan PS, Bernheim SM, Penrod JD, Boockvar KS, Federman AD, Krumholz HM, Siu AL. Use of Recommended Ambulatory Care Services: Is the Veterans Affairs Quality Gap Narrowing? JAMA Internal Medicine 2008, 168: 950-958. PMID: 18474759, DOI: 10.1001/archinte.168.9.950.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAmbulatory CareBehavioral Risk Factor Surveillance SystemBreast NeoplasmsCholesterolColorectal NeoplasmsCounselingDiabetes MellitusDiabetic RetinopathyDisease ManagementDyslipidemiasFemaleHospitals, VeteransHumansInfluenza VaccinesMaleMiddle AgedPneumococcal VaccinesPreventive Health ServicesQuality of Health CareSmoking CessationUnited StatesVeteransConceptsVeterans Affairs Medical CenterAmbulatory care servicesInsured adultsCancer screeningCare servicesBehavior Risk Factor Surveillance SystemRisk Factor Surveillance SystemCardiovascular risk reductionColorectal cancer screeningChronic disease careBreast cancer screeningQuality improvement initiativesQuality of careUS health care systemInfectious disease preventionHealth care systemHealth Care Quality Improvement InitiativeEye examinationSelf-reported useDisease careCancer preventionMellitus managementMedical CenterAmbulatory careService use
2006
The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening.
Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Annals Of Internal Medicine 2006, 145: 646-53. PMID: 17088577, DOI: 10.7326/0003-4819-145-9-200611070-00006.Peer-Reviewed Original ResearchConceptsChronic illnessColorectal cancerChronic conditionsLife expectancyCancer stageEarly-stage colorectal cancerPopulation-based cancer registriesPatients 67 yearsRetrospective cohort studyStage I cancerAdministrative claims dataChronic condition groupsFinal study sampleYears of ageShort life expectancyCohort studyEffect of agePatient ageI cancerCancer RegistryCancer variesHealthy patientsIndividual patientsMedicare claimsAdministrative claims
2005
Impact of Managed Care on Cancer Trial Enrollment
Gross CP, Krumholz HM. Impact of Managed Care on Cancer Trial Enrollment. Journal Of Clinical Oncology 2005, 23: 3811-3818. PMID: 15923575, DOI: 10.1200/jco.2005.00.430.Peer-Reviewed Original ResearchConceptsTrial enrollment ratesCancer trial enrollmentTrial enrollmentCare penetrationCooperative group trialsLow enrollment ratesNational Cancer InstituteCounty characteristicsFourth quartileTrial participationLowest quartileProstate cancerCare competitionGroup trialsCancer InstituteStrong inverse correlationBivariate analysisCare activitiesMultivariate modelParticipant dataInverse correlationEnrollment ratesManaged CareZip codesQuartile
2004
Cancer Trial Enrollment After State-Mandated Reimbursement
Gross CP, Murthy V, Li Y, Kaluzny AD, Krumholz HM. Cancer Trial Enrollment After State-Mandated Reimbursement. Journal Of The National Cancer Institute 2004, 96: 1063-1069. PMID: 15265967, DOI: 10.1093/jnci/djh193.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicColorectal NeoplasmsFemaleGovernment RegulationHumansIncidenceLogistic ModelsLongitudinal StudiesLung NeoplasmsMaleMulticenter Studies as TopicNational Institutes of Health (U.S.)NeoplasmsPatient SelectionPoisson DistributionProstatic NeoplasmsReimbursement MechanismsRetrospective StudiesState GovernmentUnited StatesConceptsCancer trial enrollmentTrial enrollment ratesTrial enrollmentMultivariable analysisTrial participationOdds ratioTrial participantsCoverage policiesCancer trial participantsCooperative group trialsClinical trial enrollmentEarly phase trialsRecruitment of patientsCancer trial participationMedical care costsPhase II trial participantsCancer patientsPhase trialsCancer research studiesGroup trialsCare costsPoisson regressionCancer typesReimbursement policiesPhase II